JCRB1648 ICH-ERMS-1
Cell information
Important Notice(s)JCRB1648: ICH-ERMS-1 - Condition for Distribution [分譲の条件]
Cell type：general cells (View Pricing Information)
| JCRB No. | JCRB1648 | Cell Name | ICH-ERMS-1 |
|---|---|---|---|
| Profile | Human cell derived from anaplastic embryonal rhabdomyosarcoma. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | F | Age | 5-year-old |
| Identity | available | Tissue for Primary Cancer | sarcoma |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | TP53 c.743G>T | |
| Life Span | infinite | Crisis PDL | |
| Morphology | spindle or polygonal | Character | |
| Classify | tumor | Established by | Kato, K. |
| Registered by | Kato, K. | Regulation for Distribution | Cite the litarature specified by the developer at the publication of papers using this cell line. |
| Comment | Year | 2015 | |
| Medium | RPMI1640 medium with 10% FBS | Methods for Passages | Trypsin/EDTA treatment |
| Cell Number on Passage | Race | ||
| CO2 Conc. | 5% | Tissue Sampling | pelvic tumor |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:33021000 | Distinct clonal evolution in a case with anaplastic embryonal rhabdomyosarcoma. Kato K,Yoshimi A,Noda A,Otani H,Hojo H,Tanaka M,Tanaka Y,Ito Y,Nishimura R,Takita J,Yanai T,Koike K,Tsuchida M Pediatr Int. 2021 Jul;63(7):782-789 |
| Images |
|---|
   |
LOT Information
| Cell No. | JCRB1648 | Cell Name | ICH-ERMS-1 |
|---|---|---|---|
| LOT No. | 11242015 | Lot Specification | distribution |
| Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA12J396) | Temperature | 37 C |
| Cell Density at Seeding | 1.3-2.7x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.03x10^6 |
| Viability at cell freezing (%) | 97.7 | Antibiotics Used | free |
| Passage Number | p4* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11 D13S317:12 D7S820:8,11 D16S539:12,13 VWA:14,18 TH01:9 AM:X TPOX:8 CSF1PO:9 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
|
|